Vitamin D3 supplementation in adult patients with non-cystic fibrosis bronchiectasis - a feasibility study

Vitamin D3 supplementation in bronchiectasis - a feasibility study

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612001222831

Enrollment

Registered

2012-11-19

Start date

2013-09-18

Completion date

2014-06-03

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to assess the range of 25(OH) D levels in adult patients with non-cystic bronchiectasis and assess whether vitamin D3 supplementation increases 25(OH) D levels above 75 nmol/L

Interventions

Cholecalciferol 25,000iu single capsule oral dose

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Patients with a diagnosis of bronchiectasis based on high resolution chest CT scan within the previous 2 years

Exclusion criteria

Patients taking Vitamin D3 supplement >600iu per day, patients with cystic fibrosis

Outcome results